Etid klinik pou Sipwa nan Miami, FL
23 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- PharmaDev Clinical Research Institute LLC, Miami
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Ap rekriteFaz 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Ap rekriteFaz 1
- Clinical Pharmacology of Miami, Miami
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
Ap rekriteFaz 1
- Clinical Pharmacology of Miami, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Ap rekriteFaz 3
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Horizon Research Center, Miami
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ap rekriteFaz 3
- Finlay Medical Research, Miami
- Suncoast Research Group LLC, Miami
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- BioMed Research & Medical Center, Miami
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Ap rekriteFaz 3
- New Horizon Research Center, Miami
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Ap rekriteFaz 3
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Miami
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Ap rekriteFaz 3
- PharmaDev Clinical Research Institute LLC, Miami
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Ap rekriteFaz 2
- New Horizon Research Center, Miami
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Optimus U Corporation, Miami
- Research Institute of South Florida, Miami
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Ap rekriteFaz 3
- Optimus U Corporation, Miami
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- New Horizon Research Center, Miami
- Research Institute of South Florida, Miami
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Miami
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Active Older Adults Prospective Cohort Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Miami-Dade County Parks, Recreation and Open Spaces Department, Miami
Etid Sipwa nan lòt vil
- Houston, TX33 etid
- San Antonio, TX33 etid
- Chicago, IL28 etid
- Orlando, FL25 etid
- Las Vegas, NV23 etid
- Dallas, TX20 etid
- Atlanta, GA20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
- Havelock, NC17 etid
Lòt etid nan Miami
- Kansè nan tete42 etid
- Kansè (tout kalite)36 etid
- Kansè Poumon ki pa ti selil31 etid
- Obèsite27 etid
- Kansè pwostat27 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
- Kansè Metastatik23 etid
- Kolit Ulseratif22 etid
- Myelom Miltip21 etid
- Kansè poumon20 etid
- Maladi Alzheimer20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.